Darzalex and Confusional state - a phase IV clinical study of FDA data

Summary:

We study 17,614 people who have side effects when taking Darzalex. Confusional state is found, especially among people who are male, 60+ old, have been taking the drug for < 1 month, also take Revlimid and have Multiple myeloma.

The phase IV clinical study analyzes which people take Darzalex and have Confusional state. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 30, 2023

17,614 people reported to have side effects when taking Darzalex.
Among them, 119 people (0.68%) have Confusional state.


What is Darzalex?

Darzalex has active ingredients of daratumumab. Currently, eHealthMe is studying from 17,627 Darzalex users.

What is Confusional state?

Confusional state is found to be associated with 3,535 drugs and 3,277 conditions by eHealthMe. Currently, we are studying 173,797 people who have Confusional state.

Number of Darzalex and Confusional state reports submitted per year:

Could Darzalex cause Confusional state?

Time on Darzalex when people have Confusional state *:

Click here to view

Gender of people who have Confusional state when taking Darzalex*:

Click here to view

Age of people who have Confusional state when taking Darzalex *:

Click here to view

Common drugs people take besides Darzalex *:

Click here to view

Common side effects people have besides Confusional state *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Darzalex and have Confusional state?

Check whether Confusional state is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Darzalex side effects by duration, gender and age:

Confusional state treatments and more:

Common drugs associated with Confusional state:

All the drugs that are associated with Confusional state:

Common conditions associated with Confusional state:

All the conditions that are associated with Confusional state:

How the study uses the data?

The study uses data from the FDA. It is based on daratumumab (the active ingredients of Darzalex) and Darzalex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: